Wei Huang

16PUBLICATIONS
17CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and designChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 15, 2026
Accelerating SuFEx Reactions via Aryl Fluorosulfate Structural Engineering for Enhanced Covalent Targeted Cancer Therapy.

|Mar 30, 2026
A smart P-gp inhibitor-drug conjugate nanomedicine overcomes administration challenges and multidrug resistance in breast cancer therapy.

Yingchun Liu, Penghui Wang, Xuelin Xia

|Jan 19, 2026
A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

Bing Liu, Guanchun Wang, Quanjun Yang

|Sep 03, 2025
A Nanodrug Self-Assembled from a Redox-Responsive Cabazitaxel-Zosuquidar Conjugate and DSPE-PEG2k Reverses Multidrug Resistance in Nonsmall Cell Lung Cancer.

Yingchun Liu, Penghui Wang, Wenhui Gao

|May 30, 2025
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer Therapy.

Xuelin Xia, Wenhui Gao, Xiaoyuan Yang

|Dec 10, 2024
Synergistic Therapy of Metastatic Breast Cancers by Biomimetic Chemotherapeutic Drug-Gene Nanoparticles.

Junjie Ren, Ying Han, Jie Xu

Pageof 3

Frequent Collaborators

8 joint publications

Deyue Yan

4 joint publications

Deyue Yan

3 joint publications

Yue Su

3 joint publications

Xuelin Xia